Symbol lookup from Yahoo Finance

Symbols similar to 'SRT'

All (40)  Stocks (33)  Mutual funds (3)  ETFs (2)  Indices (0)  Futures (0)  Currencies (0)  Cryptocurrencies (2)  

Symbol	Name	Last price	Sector / Category	Type	Exchange
SRT.F	SARTORIUS AG I	173.00	Healthcare	Stocks	FRA
SRT19517-USD	Smart Reward Token USD	0.00	--	Cryptocurrencies	CCC
SRT.DE	SARTORIUS AG I	174.40	Healthcare	Stocks	GER
6S7.F	SRT Marine Systems PLC R	0.44	Technology	Stocks	FRA
SRT.SI	CSOP iEdge SREIT ETF S$	0.75	--	ETFs	SES
SRTY	ProShares UltraPro Short Russel	15.46	--	ETFs	PCX
SRTTY	Zozo Inc.	6.34	Consumer Cyclical	Stocks	PNK
SRTOY	Sartorius Stedim Biotech	18.50	Healthcare	Stocks	PNK
SRT.L	SRT MARINE SYSTEMS PLC ORD 0.1P	38.50	Technology	Stocks	LSE
SRTG.JK	Saratoga Investama Sedaya Tbk.	2,590.00	Financial Services	Stocks	JKT
SRT.SG	Sartorius AG	174.80	Healthcare	Stocks	STU
SRT3.DU	SARTORIUS AG V	211.90	Healthcare	Stocks	DUS
SRT3.DE	SARTORIUS AG V	212.50	Healthcare	Stocks	GER
SRTS	Sensus Healthcare, Inc.	8.83	Healthcare	Stocks	NCM
SRTSF	GR.SARANTIS	11.15	Consumer Defensive	Stocks	PNK
SRT.BE	SARTORIUS AG I	176.40	Healthcare	Stocks	BER
SRT.DU	SARTORIUS AG I	174.40	Healthcare	Stocks	DUS
SRT0.F	Sartorius AG N	41.00	Healthcare	Stocks	FRA
SRT3.BE	SARTORIUS AG V	210.70	Healthcare	Stocks	BER
SRT4.DU	Sartorius AG N	33.80	Healthcare	Stocks	DUS
SRT.MU	SARTORIUS AG I	173.40	Healthcare	Stocks	MUN
SRT3D.XD	Sartorius AG	213.10	--	Stocks	DXE
SRT3D.XC	Sartorius AG	216.00	Healthcare	Stocks	CXE
SRT.HA	SARTORIUS AG I	171.80	Healthcare	Stocks	HAN
SRT3.HA	SARTORIUS AG V	211.60	Healthcare	Stocks	HAN

1-25 of 40

Related news

Wall Street Bulls Look Optimistic About Sensus Healthcare (SRTS): Should You Buy?

The average brokerage recommendation (ABR) for Sensus Healthcare (SRTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks 2 days ago

SRTS
Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 36.01%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 36% in Sensus Healthcare (SRTS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks 3 days ago

SRTS
Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Here is how Sensus Healthcare, Inc. (SRTS) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.

Zacks 3 days ago

SRTS

ALNY
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration

Full-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic visits BOCA RATON, Fla, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, has partnered with Pompano Veterinary Oncology to pioneer the use of SRT to treat companion animals

GlobeNewswire 3 days ago

SRTS
Sensus Healthcare (NASDAQ:SRTS) Knows How To Allocate Capital Effectively

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Simply Wall St. 6 days ago

SRTS
Sartorius Stedim Biotech opens bioprocess centre in the US

The facility intends to promote on-site collaboration, co-development, and learning with clients and external innovation partners.

Investment Monitor 16 days ago

SRTOY
Wall Street Analysts See a 39.66% Upside in Sensus Healthcare (SRTS): Can the Stock Really Move This High?

The mean of analysts' price targets for Sensus Healthcare (SRTS) points to a 39.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks 19 days ago

SRTS
REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer’s request. The agreement with the new customer remains in effect. Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Expects to have more than 50 IG-SRT Systems signed under the

GlobeNewswire 20 days ago

SRTS
Sensus Healthcare Third Quarter 2024 Earnings: Beats Expectations

Sensus Healthcare ( NASDAQ:SRTS ) Third Quarter 2024 Results Key Financial Results Revenue: US$8.84m (up 127% from 3Q...

Simply Wall St. 21 days ago

SRTS
Q3 2024 Sensus Healthcare Inc Earnings Call

Q3 2024 Sensus Healthcare Inc Earnings Call

Thomson Reuters StreetEvents 22 days ago

SRTS
Sensus Healthcare Inc (SRTS) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

Sensus Healthcare Inc (SRTS) reports a 127% revenue increase and a significant Fair Deal agreement, positioning for future expansion.

GuruFocus.com 23 days ago

SRTS
Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates

Sensus Healthcare (SRTS) delivered earnings and revenue surprises of 450% and 51.35%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 23 days ago

SRTS
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year agoSigned a Fair Deal Agreement with Platinum Dermatology, a leading dermatology network with 130 clinics across the U.S. Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective

GlobeNewswire 23 days ago

SRTS
Is Now An Opportune Moment To Examine Sensus Healthcare, Inc. (NASDAQ:SRTS)?

Sensus Healthcare, Inc. ( NASDAQ:SRTS ), is not the largest company out there, but it received a lot of attention from...

Simply Wall St. 28 days ago

SRTS
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

BOCA RATON, Fla., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, November 14, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming mi

GlobeNewswire last month

SRTS
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know

Sensus Healthcare, Inc. (SRTS) reachead $6.44 at the closing of the latest trading day, reflecting a +1.58% change compared to its last close.

Zacks last month

SRTS

^GSPC
Is Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Latest Stock Performance A Reflection Of Its Financial Health?

Most readers would already be aware that Sensus Healthcare's (NASDAQ:SRTS) stock increased significantly by 11% over...

Simply Wall St. last month

SRTS
Sartorius AG (SARTF) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth

Sartorius AG (SARTF) reports a mixed quarter with strong order intake and cash flow improvements, despite facing sales revenue challenges and regional market pressures.

GuruFocus.com last month

SOAGY
Sartorius Stedim Biotech SA (SDMHF) Q3 2024 Earnings Call Highlights: Navigating Market ...

Despite a slight decline in sales revenue, Sartorius Stedim Biotech SA (SDMHF) shows resilience with increased order intake and strong cash flow management.

GuruFocus.com last month

SRTOY
Sensus Healthcare, Inc. (SRTS): Medical Device Leader in 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Sensus Healthcare, Inc. (NASDAQ:SRTS) stands against other best performing cheap stocks in 2024. As we step into the final quarter of 2024, the financial markets continue to navigate a complex […]

Insider Monkey last month

SRTS

News

Finance

Symbols similar to 'SRT'

Related news

Wall Street Bulls Look Optimistic About Sensus Healthcare (SRTS): Should You Buy?

Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 36.01%: Here's is How to Trade

Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year?

Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration

Sensus Healthcare (NASDAQ:SRTS) Knows How To Allocate Capital Effectively

Sartorius Stedim Biotech opens bioprocess centre in the US

Wall Street Analysts See a 39.66% Upside in Sensus Healthcare (SRTS): Can the Stock Really Move This High?

REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Sensus Healthcare Third Quarter 2024 Earnings: Beats Expectations

Q3 2024 Sensus Healthcare Inc Earnings Call

Sensus Healthcare Inc (SRTS) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...

Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates

Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter

Is Now An Opportune Moment To Examine Sensus Healthcare, Inc. (NASDAQ:SRTS)?

Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024

Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know

Is Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Latest Stock Performance A Reflection Of Its Financial Health?

Sartorius AG (SARTF) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth

Sartorius Stedim Biotech SA (SDMHF) Q3 2024 Earnings Call Highlights: Navigating Market ...

Sensus Healthcare, Inc. (SRTS): Medical Device Leader in 2024